Cell isolation from organ or tissues represents a critical step: not only a high number of living and functional cells needs to be isolated, but also reproducible protocols and results are necessary. Ongoing protocols determine unpredictable enzymatic efficiency, low batches consistency and low stability, that can cause drawbacks in the efficiency of cell extraction and low reproducibility as well as standardization of protocols itself. Here is the best patented company goal.
Cat: Bio-Tech Industry
Amount: EUR 1 to 3 MLN